Imaging Surveillance of Patients with Breast Cancer After Primary Treatment: Current Recommendations
Overview
Affiliations
Women who have been treated for breast cancer are at risk for second breast cancers, such as ipsilateral recurrence or contralateral metachronous breast cancer. As the number of breast cancer survivors increases, interest in patient management and surveillance after treatment has also increased. However, post-treatment surveillance programs for patients with breast cancer have not been firmly established. In this review, we focus on the imaging modalities that have been used in post-treatment surveillance for patients with breast cancer, such as mammography, ultrasonography, magnetic resonance imaging, and positron emission tomography, the effectiveness of each modality for detecting recurrence, and how they can be applied to manage patients.
Jung D, Chung J, Kim J, Cha E, Kim J Korean J Radiol. 2024; 25(11):992-1002.
PMID: 39473090 PMC: 11524691. DOI: 10.3348/kjr.2023.1073.
Shinzaki W, Manabe H, Kubota M, Inui H, Hojo T, Ito T SAGE Open Med Case Rep. 2023; 11:2050313X231177510.
PMID: 37325163 PMC: 10265333. DOI: 10.1177/2050313X231177510.
Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer.
Lee H, Choi J, Park Y, Lee J, Kim S, Nam S Cancers (Basel). 2023; 15(9).
PMID: 37174111 PMC: 10177223. DOI: 10.3390/cancers15092646.
Li J, Fu N, Wang B, Jiang Y, Li S, Niu R Eur Radiol. 2023; 33(9):6482-6491.
PMID: 37074423 DOI: 10.1007/s00330-023-09594-0.
Care for Breast Cancer Survivors.
Jeong S, Park S Adv Exp Med Biol. 2021; 1187:511-524.
PMID: 33983597 DOI: 10.1007/978-981-32-9620-6_27.